FindTrial
Sign In

To study the prevalence of infections in patients with Inflammatory Bowel Disease

Infections in patients with Inflammatory Bowel Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/032350
Enrollment
200
Registered
2021-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K50- Crohns disease [regional enteritis] Health Condition 2: K51- Ulcerative colitis

Interventions

Intervention1: Nil: Nil

Sponsors

Dayanand Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Inflammatory Bowel Disease Patientââ?¬•s demonstration of understanding of study requirements and treatment procedures, willingness to comply with all protocol-required evaluations

Exclusion criteria

Exclusion criteria: Pregnant/lactating female History or other evidence of severe illness or any other conditions that would make the patient, in the opinion of the investigator, unsuitable for the study (such as poorly controlled psychiatric disease, significant co-morbidities like advanced coronary artery disease, etc.)

Design outcomes

Primary

MeasureTime frame
To study the clinical spectrum of infections in patients with Inflammatory Bowel Disease in IndiaTimepoint: 1 year—

Secondary

MeasureTime frame
To study the relationship between use of immunosuppressive drugs, nutritional status and prevalence of infectionsTimepoint: 1 year—

Countries

India

Contacts

Public ContactAjit Sood

Dayanand Medical College and Hospital Ludhiana

ajitsood10@gmail.com9815400718

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026